SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CARE reaffirms assigned ‘A1+’ rating to CP Programme of Elder Pharmaceuticals

29 Jul 2011 Evaluate

Credit rating agency, CARE has reaffirmed the assigned ‘A1+’ rating to Commercial Paper (CP) Programme carved out of WC limits of Elder Pharmaceuticals for Rs 105.00 crore. The agency has also reaffirmed the assigned ‘A1+’ rating to Commercial Paper (standalone) Programme of the company for Rs 75.00 crore.

Improvement in the overall capital structure in terms of the reduction in gearing ratios and shortening of the working capital cycle are the key rating sensitivities.

Elder Pharmaceuticals (EPL) is engaged in the manufacturing and marketing of mainly pharmaceutical formulations, under its own as well as in-licensed brands, and offers a gamut of products in the Active Pharmaceutical Ingredients (API)/bulk drugs. The company is also a distributor of the cosmeceutical products.

Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×